SHJ
NVO icon

Sharkey, Howes & Javer’s Novo Nordisk NVO Stock Holding History

Sharkey, Howes & Javer’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,466
Closed -$294K – 152
2024
Q3 		$294K Buy
2,466
+1,000
+68% +$133K 0.04% 125
2024
Q2 		$209K Buy
+1,466
New +$194K 0.03% 113

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sharkey, Howes & Javer's NVO Position: Q4 2024 in Review

Sharkey, Howes & Javer sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,466 shares — an estimated $294K sold.

Sharkey, Howes & Javer first reported a position in NVO in Q2 2024 and held it in 2 quarters. The position peaked at $294K in Q3 2024. 1,667 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Sharkey, Howes & Javer reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Sharkey, Howes & Javer sold 2,466 Novo Nordisk shares in Q4 2024, an estimated $294K.
  • Sharkey, Howes & Javer first reported a position in Novo Nordisk in Q2 2024 and held it in 2 quarters.
  • Sharkey, Howes & Javer's Novo Nordisk position peaked at $294K in Q3 2024.
  • 1,667 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Sharkey, Howes & Javer's 13F filing for Q4 2024, filed 5 Feb 2025.